Terms: = Head and neck cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3
375 results:
1. Combined
Montoro-Jiménez I; Granda-Díaz R; Menéndez ST; Prieto-Fernández L; Otero-Rosales M; Álvarez-González M; García-de-la-Fuente V; Rodríguez A; Rodrigo JP; Álvarez-Teijeiro S; García-Pedrero JM; Hermida-Prado F
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473941
[TBL] [Abstract] [Full Text] [Related]
2. Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes.
Pravallika G; Rajasekaran R
BMC Genomics; 2024 Feb; 25(1):135. PubMed ID: 38308202
[TBL] [Abstract] [Full Text] [Related]
3. SEPT9, H4C6, and RASSF1A methylation in nasopharyngeal swabs: A reflection of potential minimally invasive biomarkers for early screening of nasopharyngeal cancer.
Qian T; Zhou Z; Zhang Q; Liou YL; Zhou H
Medicine (Baltimore); 2023 Dec; 102(50):e36583. PubMed ID: 38115290
[TBL] [Abstract] [Full Text] [Related]
4. The impact of LncRNA-sox2-OT/let-7c-3p/SKP2 Axis on head and neck squamous cell carcinoma progression: Insights from bioinformatics analysis and experimental validation.
Wang D; Zhao X; Li S; Guo H; Li S; Yu D
Cell Signal; 2024 Mar; 115():111018. PubMed ID: 38110167
[TBL] [Abstract] [Full Text] [Related]
5. sox2 promotes a cancer stem cell-like phenotype and local spreading in oral squamous cell carcinoma.
Sacco A; Battaglia AM; Santamaria G; Buffone C; Barone S; Procopio A; Lavecchia AM; Aversa I; Giorgio E; Petriaggi L; Cristofaro MG; Biamonte F; Giudice A
PLoS One; 2023; 18(12):e0293475. PubMed ID: 38096163
[TBL] [Abstract] [Full Text] [Related]
6. Chaperonin containing TCP1 subunit 6A may activate Notch and Wnt pathways to facilitate the malignant behaviors and cancer stemness in oral squamous cell carcinoma.
Chen Y; Chen Y; Liu W
Cancer Biol Ther; 2024 Dec; 25(1):2287122. PubMed ID: 38084868
[TBL] [Abstract] [Full Text] [Related]
7. Super-enhancer driven sox2 promotes tumor formation by chromatin re-organization in nasopharyngeal carcinoma.
Liu SX; Wang C; Lin RB; Ding WY; Roy G; Wang HB; Yang T; Liu Q; Luo YL; Jin SL; Zeng MS; Zhao B; Zhong Q
EBioMedicine; 2023 Dec; 98():104870. PubMed ID: 37967508
[TBL] [Abstract] [Full Text] [Related]
8. Cytotoxic Imidazolyl-Mesalazine Ester-Based Ru(II) Complexes Reduce Expression of Stemness Genes and Induce Differentiation of Oral Squamous Cell Carcinoma.
Kumari P; Ghosh S; Acharya S; Mitra P; Roy S; Ghosh S; Maji M; Singh S; Mukherjee A
J Med Chem; 2023 Oct; 66(20):14061-14079. PubMed ID: 37831489
[TBL] [Abstract] [Full Text] [Related]
9. The DMRTA1-sox2 positive feedback loop promotes progression and chemotherapy resistance of esophageal squamous cell carcinoma.
Zhang R; Zhou P; Ou X; Zhao P; Guo X; Xi M; Qing C
Oncol Res; 2023; 31(6):887-897. PubMed ID: 37744275
[TBL] [Abstract] [Full Text] [Related]
10. Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC.
Wamsley NT; Wilkerson EM; Guan L; LaPak KM; Schrank TP; Holmes BJ; Sprung RW; Gilmore PE; Gerndt SP; Jackson RS; Paniello RC; Pipkorn P; Puram SV; Rich JT; Townsend RR; Zevallos JP; Zolkind P; Le QT; Goldfarb D; Major MB
Mol Cell Proteomics; 2023 Nov; 22(11):100647. PubMed ID: 37716475
[TBL] [Abstract] [Full Text] [Related]
11. METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of sox2 in metastasis and radiosensitivity of nasopharyngeal carcinoma.
Hu X; Wu J; Feng Y; Ma H; Zhang E; Zhang C; Sun Q; Wang T; Ge Y; Zong D; Chen W; He X
Clin Transl Med; 2023 Sep; 13(9):e1361. PubMed ID: 37658588
[TBL] [Abstract] [Full Text] [Related]
12. Vemurafenib activates the sonic hedgehog pathway and promotes thyroid cancer stem cell self-renewal.
Lu Y; Zhao Y; Liu P; Xu X
Endocr Relat Cancer; 2023 Nov; 30(11):. PubMed ID: 37643458
[TBL] [Abstract] [Full Text] [Related]
13. Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating patched homolog 1 via N6-methyladenosine methylation.
Liang H; Fang C; Zhang L
Am J Physiol Cell Physiol; 2023 Sep; 325(3):C770-C779. PubMed ID: 37575058
[TBL] [Abstract] [Full Text] [Related]
14. IL-1β transgenic mouse model of inflammation driven esophageal and oral squamous cell carcinoma.
Muthupalani S; Annamalai D; Feng Y; Ganesan SM; Ge Z; Whary MT; Nakagawa H; Rustgi AK; Wang TC; Fox JG
Sci Rep; 2023 Aug; 13(1):12732. PubMed ID: 37543673
[TBL] [Abstract] [Full Text] [Related]
15. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/sox2 pathway.
Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
[TBL] [Abstract] [Full Text] [Related]
16. Low Expression of BIRC5-206 Promotes cancer Progression in Nasopharyngeal Carcinoma via Enhancing Expression of Stem Cell Markers.
Chen X; Xu W; Ma Z; Shen L; Xie Y; Zhu X; Hu J; Zhang Y; Fu Z; Fu S
Ann Clin Lab Sci; 2023 May; 53(3):380-388. PubMed ID: 37437934
[TBL] [Abstract] [Full Text] [Related]
17. Control of sox2 protein stability and tumorigenic activity by E3 ligase CHIP in esophageal cancer cells.
Kang L; Zhang H; Wang Y; Chu M; He J; Xue M; Pan L; Zhang Y; Wang Z; Chen Z; Huang Y; Chen Z; Li E; Li J; Xu L; Zhang R; Wong J
Oncogene; 2023 Jul; 42(30):2315-2328. PubMed ID: 37353616
[TBL] [Abstract] [Full Text] [Related]
18. GSK3β-driven sox2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma.
Kang L; Liu Y; He J; Wang Y; Xue M; Wu X; Wang Z; Zhang Y; Chu M; Li J; Wei W; Li J; Li E; Liao L; Xiao J; Zhang R; Xu L; Wong J
Oncogene; 2023 Jul; 42(30):2297-2314. PubMed ID: 37349645
[TBL] [Abstract] [Full Text] [Related]
19. The roles of the sox2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy.
Zhang J; Wang Z; Zhao H; Wei Y; Zhou Y; Zhang S; Zhao J; Li X; Lin Y; Liu K
Biomed Pharmacother; 2023 Jul; 163():114764. PubMed ID: 37100016
[TBL] [Abstract] [Full Text] [Related]
20. Reactivated thyroid hormone receptor β attenuates anaplastic thyroid cancer (ATC) stem cell activity.
Zhu X; Zhao L; Doolittle WKL; Cheng SY
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36939877
[TBL] [Abstract] [Full Text] [Related]
[Next]
